Research protocol on the usage of the Dexamethasone Suppression Test (DST) as a biological indicator of depressive illness. WHO collaborative study.
D002986:Clinical Trials as Topic / Q000592:standards; D003866:Depressive Disorder / Q000503:physiopathology*; D003907:Dexamethasone; D006801:Humans
D003907:Dexamethasone